March 3, 2021 Epidemiology The pained expression of Dr. Anthony Fauci said it all in response to Texas governor’s decision to eliminate Covid-19 mask mandate and allow 100 per cent business occupancy.
March 2, 2021 Epidemiology Ontario mulling extending dosing interval of Covid-19 vaccine to four months. If there is definitive evidence supporting this policy change, then it should be enacted.
March 1, 2021 Alternative Medicine College of Physicians and Surgeons of Ontario seeks input from members about policy changes for non-evidenced-based therapies.
February 25, 2021 Allergy/Immunology Study proposes a biological mechanism to explain how high fructose exposure can exacerbate immune inflammatory response.
February 24, 2021 Epidemiology Education workers ask to be included as part of the next COVID-19 vaccination phase. It can contribute to a stable school year, improve children’s mental health and pedagogic stability, teacher security, and reduces family stress and yo-yo closures.
February 19, 2021 Epidemiology What is behind recent COVID-19 case reductions? An aggregate of factors with disproportionate influences thought to be contributing factors: social distancing, seasonality, seroprevalence, and shots.
February 18, 2021 Clinical Research In vitro studies reported in NEJM show that Pfizer/Moderna vaccines were still able to neutralize variant B.1.351 from South Africa despite reduction in neutralizing antibodies. Authors’ opinion is that vaccine remains efficacious. More to follow.
February 17, 2021 Epidemiology Oops! Didn’t think That would happen: Technology Executive Apologizes After Dozens of Event Attendees Contract Covid-19 🙄
February 16, 2021 Bariatric Medicine NEJM publishes study evaluating the use of semaglutide to assist people with weight loss. Not “game-changing” but another positive step forward for evidenced-based treatment to help people with #Overweight or #Obesity.
February 15, 2021 Clinical Research Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older.—- Restriction-easing plan in Ontario risks Yo-Yo effect once again.
